Characteristic | Value |
---|---|
Age [years] | 69 (45–89) |
PSA [ng/dl] | 70 (0.3–4742) |
Time from initial diagnosis [years] | |
≤ 2 | 18 (27.3%) |
> 2 to ≤ 5 | 20 (30.3%) |
> 5 | 28 (42.4%) |
Prior therapy | |
Prostatectomy | 29 (44%) |
Radiation | 39 (59%) |
ADT | 66 (100%) |
Enzalutamide | 50 (76%) |
Abiraterone | 47 (71%) |
Docetaxel | 37 (56%) |
Cabazitaxel | 24 (36%) |
Xofigo | 7 (11%) |
ECOG PS before first cycle | |
0 | 18 (27%) |
1 | 41 (62%) |
2 | 5 (8%) |
3 | 2 (3%) |
Site of metastasis | |
Bone | 60 (91%) |
Lymph node | 49 (74%) |
Liver | 29 (44%) |
Lung | 10 (15%) |